... create Japan's second-largest drugs firm, they said in a joint statement.. US Panel: AstraZeneca Heart Drug OK with Others Reuters-USA By Susan Heavey. ROCKVILLE, Md. (Reuters)-AstraZeneca Plc should be allowed to market its hypertension drug Atacand to heart failure patients taking other. US Poll Backs Bigger Gov't Role on Drug Prices Reuters-USA Sixty-five percent of the 1, 200 adults polled said they want more government regulation of drug prices, while 14 percent said there was too much regulation.. Par Pharmaceutical 4Q profit plunges BusinessWeek-USA 24 10: 30 AM ET Par Pharmaceutical Cos.. Par Pharmaceutical shares fell 98 cents, or 2.5 percent, to $37.89 in morning trading on the New York Stock Exchange.. Par Pharmaceutical Reports Sales and Earnings for 2004 Yahoo News (press release)-USA 24 / PRNewswire-FirstCall /-Par Pharmaceutical Companies, Inc.. NanoCrystal (R) Dispersion is a registered trademark of Elan Pharmaceutical International, Ltd.. Drug Benefit Will Boost Government's Financial Burden Forbes-USA 23 (HealthDay ...

... deaths aren't enough for the Food and Drug Administration to follow Canada in. Shoppers Drug's 4th-Qtr Net Rises 27 %; Revenue Climbs (Update2) Bloomberg-USA 10 (Bloomberg)-Shoppers Drug Mart Corp, Canada's biggest drugstore chain, said fourth-quarter profit rose 27 percent as the company expanded stores and. Obesity drug obstacles CNN-USA NEW YORK (CNN / Money)-Millions of Americans are still waiting for their weight loss wonder drug, and the inventor of such a drug stands to make a fortune.. Par Pharmaceutical to Host Fourth-Quarter Earnings Conference Call. Yahoo News (press release)-USA SPRING VALLEY, NY, Feb. 10 / PRNewswire-FirstCall /-Par Pharmaceutical Companies, Inc. (NYSE. Par Pharmaceutical Companies, Inc. develops. Teva Pharmaceutical initiated with" overweight" New Ratings-USA NEW YORK, February 10 (newratings.com)-Analysts at Prudential Financial initiate coverage of Teva Pharmaceutical (TEVA.NAS) with an" overweight" rating.. Advancis Pharmaceutical Reports Fourth Quarter and Full Year 2004. Yahoo News (press release) ...

... prosecution that he had given the boy only the starter dosage of the drug. (Wednesday's testimony).. Gilead's HIV Combo Drug Beats Glaxo's Forbes-USA reported Thursday that HIV-infected patients on a treatment regimen using the company's antiretroviral combination drug Truvada had lower concentrations of the. Hospira to Present at the Merrill Lynch Global Pharmaceutical. Yahoo News (press release)-USA. president, Finance, and chief financial officer, will make a formal presentation on the company at the Merrill Lynch Global Pharmaceutical, Biotechnology &. Par Pharmaceutical to Present at Merrill Lynch Global. PharmaLive.com (press release)-Newtown, PA, USA SPRING VALLEY, NY, February 03, 2005 / PRNewswire-FirstCall /-Par Pharmaceutical Companies, Inc.. Par Pharmaceutical Companies, Inc.. Adhd Drug Warning over Liver Problems Scotsman-Edinburgh, Scotland, UK Doctors and patients were today warned that a drug used to treat hyperactive children may sometimes be linked to liver problems.. Applied Biosystems to Webcast Presentation at Merrill Lynch Global. Business Wire (press release)-San Francisco ...

... 33 countries for a $10 billion drug, Atorvastatin Calcium, that supposedly. Discovery Labs Sees Drug Launch Delay Reuters-USA Discovery, whose shares plunged 23 percent, had expected the US Food and Drug Administration to make a decision on whether to approve the drug, Surfaxin, by Feb. Pfizer Cancer Drug Could Arrive A Year Early Forbes-USA. of a promising cancer pill being developed by Pfizer (nyse: PFE-news-people) has been stopped earlier than expected because the drug proved effective. Par Pharmaceutical to Market Verapamil Hydrochloride Extended. Yahoo News (press release)-USA SPRING VALLEY, NY, Feb. 1 / PRNewswire-FirstCall /-Par Pharmaceutical Companies, Inc. (NYSE. Par Pharmaceutical Companies, Inc. develops. KV Pharmaceutical Reports Record Revenues for Fiscal 2005 Third. PR Newswire (press release)-USA. 1 / PRNewswire-FirstCall /-KV Pharmaceutical Company (NYSE: KVA, KVB) today reported results for the third quarter and nine months of fiscal 2005 ended. 75 %of Pharmaceutical Executives Say Long-Term Resource ...

... abbott laboratories, act, adhd drug, allergy drug, attention deficit drug, businessweek, counterfeit flu drug, cylert, diet drug, drug, drug administration, drug co, drug makers, federal reserve chairman, generic drug, generic drug pact, generic version, generic versions, glaxosmithkline, h5n1, liver, long island, low-dose, marketing applications, mn pharmaceuticals, nasonex, oil, pandemic, par, pharmaceutical company, rapid response team, roche holding ag, schering-plough, strong earnings, strong sales, swiss pharmaceutical company, tamiflu, turkish drug maker, turnaround phase, us fda, vytorin, wall street, xenical ...

... Betterchem Health Drug Information DMFs Portal 21CFR Search Site Map [search archive only] Health and Pharmaceutical News Archive News Search Tools News Search | Generic Drug Companies | Company Name | API | Pharma Stocks | News-Archive Today's News | Note: News feeds may no longer be available for the articles on this page. Par licensee gets OK for generic Remeron BusinessWeek-USA SEP. 1 2: 10 PM ET Par Pharmaceutical Cos. said Thursday that its licensing partner Amide Pharmaceutical Inc. received Food and Drug. FDA approves drug for children with short stature MSN Money-USA The Food and Drug Administration has approved the first drug to treat the condition. It provides an alternative to growth hormones. Firm says its anticancer drug can increase risk of heart problems Boston Globe-United States By Reuters | September 1, 2005. WASHINGTON-An early review of a recent study indicates that the anticancer drug Herceptin, produced by Genentech Inc.. FDA OKs Experimental Drug Injections for Short Children Los Angeles Times-CA, USA The Food and Drug Administration approved ...

... 12: 39 PM 8 / 7 / 2007 Reuters-USA Baxter International Inc. said it has expanded the recall of its Colleague and Flo-Gard drug infusion pumps. Devices sent to its Phoenix service center may have been returned to customers without required work being done.. Toyama Chem may sell bird flu drug rights early 6: 27 AM 8 / 7 / 2007 Reuters-USA Japanese drug maker Toyama Chemical said that it may sell development and marketing rights to a promising bird flu drug candidate during early trials.. Par Pharmaceutical begins shipment of generic Toprol-Xl 5: 17 AM 8 / 7 / 2007 Pharmaceutical Business Review-USA Par Pharmaceutical begins shipping metoprolol succinate extended release 50mg tablets. It's a licensed generic of AstraZeneca's Troprol-XL tablet.. FDA OKs new version Indevus drug Sanctura 5: 00 PM 8 / 6 / 2007 Bizjournals.com-Charlotte, NC, USA Indevus Pharmaceuticals Inc. said it received FDA approval for Sanctura XR, an extended-release version of its previously approved overactive-bladder drug. The newly approved. Novartis loses case in India over patent for anti-cancer drug ...

... drug Bextra on Friday because of risks of heart attacks and strokes. Bextra. Canada says Bextra drug will not return to market 4: 30 PM 12 / 16 / 2005 Reuters Canada-Toronto, Canada OTTAWA (Reuters)-Pfizer Inc 's arthritis drug Bextra, which it voluntarily suspended in April, will not return to the Canadian market, the federal government. Par Pharma jumps on antibiotic rights 4: 30 PM 12 / 16 / 2005 BusinessWeek-USA DEC. 16 12: 04 PM ET Shares of Par Pharmaceutical Cos. jumped Friday after the drug maker said it is buying the distribution rights. Roche to Seek Approval for Anemia Drug 4: 10 PM 12 / 16 / 2005 MSN Money-USA NUTLEY, NJ (AP)-Swiss drug maker Roche Holding Ltd. said Friday that it will file a marketing application with the Food and Drug. | Today's News FindingHealthOnline | Drug Thesaurus | Brand Names | Generic Names | News Digests | For Industry Keywords from the articles above: anemia, antibiotic, appendicitis, arthritis, astellas, ...

... Co. Inc. granted a licence to South African generic drugmaker Adcock Ingram to manufacture the AIDS drug efavirenz. This will be through its local subsidiary MSD Pty Ltd. South Africa's Aspen Pharmacare had previously received a licence to produce the life-prolonging anti-retroviral drug known by the trade name stocrin.. AstraZeneca, POZEN progress arthritis pain drug 6: 20 AM 9 / 7 / 2007 Reuters-USA AstraZeneca Plc is starting final Phase III clinical trials of an experimental treatment for arthritis pain with U.S. partner POZEN Inc.. Par Pharmaceutical Swings to 4Q Profit 5: 37 AM 9 / 7 / 2007 Forbes-NY, USA Par Pharmaceutical Companies Inc. reported profit for the fourth quarter and fiscal 2006. The regulatory filing had been delayed by accounting and restatement issues.. American Oriental Bioengineering Completes Acquisition of. 9: 26 AM 9 / 6 / 2007 CNNMoney.com-USA American Oriental Bioengineering, Inc. is a manufacturer and distributor of plant-based pharmaceutical and nutraceutical products. They announced the acquisition of Changchun Xinan Pharmaceutical Group Company Limited.. China Aoxing Pharmaceutical Company ...

... Pharmaceutical Address Book [pharma company sites | other search portals] Search for: PAR PHARMACEUTICAL INC, ATTN: REGULATORY AFFAIRS, 1 RAM RIDGE RD, SPRING VALLEY, NY 10977, UNITED STATES Home Page 2009 Betterchem.com Site Map ...